Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.
$0.82
As of 03/05/2021 IEX book CBOE book
2021 © Stock Market MBA, Inc.